A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Public ClinicalTrials.gov record NCT03150589. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Randomised, Double-masked, Parallel Group, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity Between SB11 and Lucentis® in Subjects With Neovascular Age-related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a randomised, double-masked, parallel group, multicentre study to evaluate the efficacy, safety, pharmacokinetics and immunogenicity of SB11 compared to Lucentis® in subjects with neovascular AMD.
Study identification
- NCT ID
- NCT03150589
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 705 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2018 (Actual)
- Primary completion
- May 24, 2019 (Actual)
- Completion
- Dec 9, 2019 (Actual)
- Last update posted
- May 21, 2021
2018 – 2019
United States locations
- U.S. sites
- 19
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina consultants San Diego | Poway | California | 92064 | — |
| Retina Consultants of Southern Colorado | Colorado Springs | Colorado | 80909 | — |
| Retina Consultants | Fort Myers | Florida | 33912 | — |
| Southeast Retina Center | Augusta | Georgia | 30909 | — |
| Retina Consultants of Hawaii | ‘Aiea | Hawaii | 96701 | — |
| Raj K. Maturi, MD, PC | Indianapolis | Indiana | 46280 | — |
| Retina Center of New Jersey, LLC | Bloomfield | New Jersey | 07003 | — |
| NJ Retina | Toms River | New Jersey | 08755-8063 | — |
| LIVR | Great Neck | New York | 11021 | — |
| Long Island Vitreoretinal Consultants | Hauppauge | New York | 11788 | — |
| Retina Associates of Western NY | Rochester | New York | 14620 | — |
| Retina Vitreous Surgeons fo Central NY, PC | Syracuse | New York | 13224 | — |
| Retina Associates of Cleveland | Middleburg Heights | Ohio | 44130 | — |
| Charleston Neuroscience Institute | Ladson | South Carolina | 29414 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Retina Research Institute of Texas | Abilene | Texas | 79606 | — |
| Austin Restina Associates | Austin | Texas | 78705 | — |
| Retina consultants of Houston | Conroe | Texas | 77030 | — |
| Retina Consultants of Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03150589, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2021 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03150589 live on ClinicalTrials.gov.